1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow imdevimab: new trials by email Literature Review of imdevimab trials Research Report on imdevimab
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Use of Monoclonal Antibodies for the Treatment of Mild to Moderate COVID-19 in Non-Hospitalized Setting BAMLANIVIMAB, CASIRIVIMAB, IMDEVIMAB - Covid19 | Phase 2 | Unknown | Sohail Rao | 1000 | 2020-11-20 | 2022-03-29 |
COVID-19 (1)
Sohail Rao (1)
United States (1)
Sohail Rao, MD (1)